{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:09:38Z","timestamp":1793722178354,"version":"4.6.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.cgh.2021.11.038","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T21:36:51Z","timestamp":1638567411000},"page":"619-629.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":197,"title":["An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD"],"prefix":"10.1016","volume":"21","author":[{"given":"Grace En Hui","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansel","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng Han","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yip Han","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen Hui","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren Jun Hao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie Ning","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieling","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe Wen-Min","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas WS.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice Xiang","family":"Xuan Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Shadab","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Noureddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun J.","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9724-4743","authenticated-orcid":false,"given":"Mark D.","family":"Muthiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2021.11.038_bib1","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2021.11.038_bib2","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","volume":"64","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.11.038_bib3","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.11.038_bib4","article-title":"A clinical overview of NAFLD: a guide to diagnosis, the clinical features, and complications \u2013 what the non-specialist needs to know","author":"Muthiah","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.cgh.2021.11.038_bib5","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2021.11.038_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gtc.2019.09.007","article-title":"Burden of disease due to nonalcoholic fatty liver disease","volume":"49","author":"Muthiah","year":"2020","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.cgh.2021.11.038_bib7","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.cgh.2021.09.021","article-title":"A meta-analysis on the global prevalence, risk factors and screening of coronary heart disease in nonalcoholic fatty liver disease","volume":"20","author":"Kai Toh","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.11.038_bib8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.11.038_bib9","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/s41395-018-0088-6","article-title":"NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances","volume":"113","author":"Noureddin","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2021.11.038_bib10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.11.038_bib11","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2021.11.038_bib12","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A\u00a0new Definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.11.038_bib13","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.dld.2021.05.014","article-title":"MAFLD vs NAFLD: where are we?","volume":"53","author":"Mantovani","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2021.11.038_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41575-020-0316-6","article-title":"From NAFLD to MAFLD: when pathophysiology succeeds","volume":"17","author":"Tilg","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.11.038_bib15","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.31420","article-title":"From NAFLD to MAFLD: implications of a premature change in terminology","volume":"73","author":"Younossi","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.11.038_bib16","doi-asserted-by":"crossref","first-page":"13844","DOI":"10.1038\/s41598-021-93435-x","article-title":"The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases","volume":"11","author":"Fujii","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.cgh.2021.11.038_bib17","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.cgh.2020.10.046","article-title":"Impact of the new Definition of metabolic associated fatty liver disease on the epidemiology of the disease","volume":"19","author":"Wong","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.11.038_bib18","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1111\/liv.14548","article-title":"Comparison of MAFLD and NAFLD diagnostic criteria in real world","volume":"40","author":"Lin","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2021.11.038_bib19","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2021.11.038_bib20","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2021.11.038_bib21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.cgh.2021.11.038_bib22","unstructured":"Moola S, Munn Z, Tufanaru C, et\u00a0al. Chapter 7: systematic reviews of etiology and risk. In. Joanna Briggs Institute Reviewer's Manual. The Joanna Briggs Institute;\u00a02017."},{"key":"10.1016\/j.cgh.2021.11.038_bib23","doi-asserted-by":"crossref","first-page":"h4419","DOI":"10.1136\/bmj.h4419","article-title":"What is publication bias in a meta-analysis?","volume":"351","author":"Sedgwick","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2021.11.038_bib24","unstructured":"Team R. RStudio: Integrated Development Environment for R. In. RStudio;\u00a02020."},{"key":"10.1016\/j.cgh.2021.11.038_bib25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jrsm.1348","article-title":"Seriously misleading results using inverse of Freeman-Tukey double arcsine transformation in meta-analysis of single proportions","volume":"10","author":"Schwarzer","year":"2019","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.cgh.2021.11.038_bib26","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","article-title":"The use of confidence or fiducial limits illustrated in the case of the binomial","volume":"26","author":"Clopper","year":"1934","journal-title":"Biometrika"},{"key":"10.1016\/j.cgh.2021.11.038_bib27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2021.11.038_bib28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/XEB.0000000000000065","article-title":"Fixed or random effects meta-analysis? Common methodological issues in systematic reviews of effectiveness","volume":"13","author":"Tufanaru","year":"2015","journal-title":"Int J Evid Based Healthc"},{"key":"10.1016\/j.cgh.2021.11.038_bib29","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2021.11.038_bib30","article-title":"Metabolic dysfunction-associated fatty liver disease and mortality among Chinese adults: a prospective cohort study","author":"Wang","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cgh.2021.11.038_bib31","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/hepr.13685","article-title":"MAFLD better predicts the progression of atherosclerotic cardiovascular risk than NAFLD: generalized estimating equation approach","volume":"51","author":"Tsutsumi","year":"2021","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cgh.2021.11.038_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245762","article-title":"Outcomes of NAFLD and MAFLD: results from a community-based, prospective cohort study","volume":"16","author":"Niriella","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2021.11.038_bib33","doi-asserted-by":"crossref","first-page":"154779","DOI":"10.1016\/j.metabol.2021.154779","article-title":"The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: a prospective analysis","volume":"120","author":"Liu","year":"2021","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.cgh.2021.11.038_bib34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1210\/clinem\/dgab641","article-title":"Association of MAFLD with diabetes, chronic kidney disease, and cardiovascular disease: a 4.6-year cohort study in China","volume":"107","author":"Liang","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cgh.2021.11.038_bib35","doi-asserted-by":"crossref","first-page":"451","DOI":"10.5009\/gnl20218","article-title":"Clinical and histologic features of patients with biopsy-proven metabolic dysfunction-associated fatty liver disease","volume":"15","author":"Huang","year":"2021","journal-title":"Gut Liver"},{"key":"10.1016\/j.cgh.2021.11.038_bib36","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.2147\/DMSO.S316096","article-title":"MAFLD criteria may overlook a subtype of patient with steatohepatitis and significant fibrosis","volume":"14","author":"Huang","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.cgh.2021.11.038_bib37","doi-asserted-by":"crossref","first-page":"5462","DOI":"10.3390\/ijms22115462","article-title":"Non-obese MAFLD is associated with colorectal adenoma in health check examinees: a multicenter retrospective study","volume":"22","author":"Fukunaga","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cgh.2021.11.038_bib38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12986-021-00611-x","article-title":"Prevalence and risk factors of metabolic associated fatty liver disease in the contemporary South China population","volume":"18","author":"Fan","year":"2021","journal-title":"Nutr Metab (London)"},{"key":"10.1016\/j.cgh.2021.11.038_bib39","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12876-021-01782-w","article-title":"Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.cgh.2021.11.038_bib40","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1111\/liv.14675","article-title":"MAFLD identifies patients with significant hepatic fibrosis better than NAFLD","volume":"40","author":"Yamamura","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2021.11.038_bib41","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.3390\/ijerph17061818","article-title":"Prevalence and risk factors of metabolic associated fatty liver disease in Xinxiang, China","volume":"17","author":"Li","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.cgh.2021.11.038_bib42","article-title":"Metabolic dysfunction associated fatty liver disease improves detection of high liver stiffness: the Rotterdam study","author":"van Kleef","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.11.038_bib43","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1210\/clinem\/dgab339","article-title":"Metabolic dysfunction-associated fatty liver disease (MAFLD)\u2014rather a bystander than a driver of mortality","volume":"106","author":"Semmler","year":"2021","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.cgh.2021.11.038_bib44","doi-asserted-by":"crossref","first-page":"100231","DOI":"10.1016\/j.jhepr.2021.100231","article-title":"NAFLD and MAFLD as emerging causes of HCC: a populational study","volume":"3","author":"Myers","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.cgh.2021.11.038_bib45","doi-asserted-by":"crossref","first-page":"8993","DOI":"10.3390\/ijerph18178993","article-title":"Open issues in the transition from NAFLD to MAFLD: the experience of the Plinio Study","volume":"18","author":"Baratta","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.cgh.2021.11.038_bib46","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1097\/CM9.0000000000001513","article-title":"Cardiovascular and renal burdens of metabolic associated fatty liver disease from serial US national surveys, 1999-2016","volume":"134","author":"Zhang","year":"2021","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.cgh.2021.11.038_bib47","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/liv.14828","article-title":"Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population","volume":"41","author":"Ciardullo","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.cgh.2021.11.038_bib48","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s12072-021-10157-y","article-title":"Does the risk of cardiovascular events differ between biopsy-proven NAFLD and MAFLD?","volume":"15","author":"Guerreiro","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cgh.2021.11.038_bib49","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2021.11.038_bib50","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease - a global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.11.038_bib51","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.jhep.2020.10.015","article-title":"Non-alcoholic fatty liver disease: not time for an obituary just yet","volume":"74","author":"Singh","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.11.038_bib52","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.cgh.2017.02.031","article-title":"Diagnostic accuracy of noninvasive fibrosis scores in a population of individuals with a low prevalence of fibrosis","volume":"15","author":"Mahady","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.11.038_bib53","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrgastro.2015.35","article-title":"Alcoholic liver disease: mechanisms of injury and targeted treatment","volume":"12","author":"Louvet","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.11.038_bib54","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies","volume":"69","author":"Pimpin","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2021.11.038_bib55","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.cgh.2020.08.012","article-title":"Associations between reproductive and hormone-related factors and risk of nonalcoholic fatty liver disease in a multiethnic population","volume":"19","author":"Wang","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2021.11.038_bib56","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2021.11.038_bib57","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13098-020-00570-y","article-title":"NAFLD as a continuum: from obesity to metabolic syndrome and diabetes","volume":"12","author":"Godoy-Matos","year":"2020","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.cgh.2021.11.038_bib58","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MD.0b013e3182779d49","article-title":"Nonalcoholic fatty liver disease in lean individuals in the United States","volume":"91","author":"Younossi","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cgh.2021.11.038_bib59","doi-asserted-by":"crossref","first-page":"665","DOI":"10.4103\/2230-8210.113758","article-title":"Clinicopathological characteristics and metabolic profiles of non-alcoholic fatty liver disease in Indian patients with normal body mass index: do they differ from obese or overweight non-alcoholic fatty liver disease?","volume":"17","author":"Kumar","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.cgh.2021.11.038_bib60","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1038\/s41598-017-04631-7","article-title":"Liver fat, hepatic enzymes, alkaline phosphatase and the risk of incident type 2 diabetes: a prospective study of 132,377 adults","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.cgh.2021.11.038_bib62","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1002\/hep4.1593","article-title":"ALT levels for Asians with metabolic diseases: a meta-analysis of 86 studies with individual patient data validation","volume":"4","author":"Huang","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.cgh.2021.11.038_bib63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/ebmental-2019-300129","article-title":"Challenges in meta-analyses with observational studies","volume":"23","author":"Metelli","year":"2020","journal-title":"Evid Based Ment Health"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356521012763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356521012763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:41:14Z","timestamp":1761543674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356521012763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1542356521012763"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2021.11.038","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2021.11.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the AGA Institute","name":"copyright","label":"Copyright"}]}}